# RGS6

## Overview
RGS6 (Regulator of G protein signaling 6) is a gene that encodes a member of the RGS protein family, specifically categorized as a GTPase-activating protein (GAP). The protein product of RGS6 plays a pivotal role in modulating G protein-coupled receptor (GPCR) signaling pathways by accelerating the deactivation of Gα subunits, thereby influencing various physiological processes. RGS6 is characterized by its structural domains, including the DEP and GGL domains, which are essential for its membrane targeting and interaction with other proteins, such as the atypical Gβ5 subunit. This interaction is crucial for the stability and function of RGS6 within the R7 subfamily of RGS proteins. The protein exists in multiple isoforms due to alternative splicing, which allows it to participate in diverse cellular functions, including neuronal signaling, cardiovascular regulation, and cancer suppression. RGS6's involvement in these processes underscores its significance in maintaining cellular homeostasis and its potential implications in various diseases, such as Parkinson's disease and non-small cell lung cancer (Yang2023Function; AhlersDannen2021Protein; Wang2022RGS6).

## Structure
RGS6 (Regulator of G protein signaling 6) is a member of the R7 subfamily of RGS proteins, characterized by the presence of DEP and GGL domains, which are crucial for membrane targeting and protein stability (AhlersDannen2021Protein). The primary structure of RGS6 includes a conserved RGS domain, which is essential for its function in modulating G protein-coupled receptor signaling (Israeli2019RGS6). The protein exists in multiple isoforms due to alternative mRNA splicing, resulting in 36 predicted protein isoforms with either long (RGS6L) or short (RGS6S) N-terminal domains, and nine alternative C-terminal sequences (AhlersDannen2021Protein).

The tertiary structure of RGS6 is modeled based on the RGS9/Gb5 complex, highlighting the importance of the DEP/DHEX and GGL domains in its structural configuration (AhlersDannen2021Protein). The GGL domain is particularly important for forming a stable dimer with the atypical Gb5 subunit, which is a key feature of the quaternary structure in the R7 RGS protein subfamily (AhlersDannen2021Protein).

RGS6 undergoes post-translational modifications, including phosphorylation, which affects the mobility and function of its isoforms. Notably, a 65-kDa phosphorylated form and a 69-kDa dephosphorylated form have been identified, with phosphorylation influencing their detection in brain tissues (AhlersDannen2021Protein).

## Function
RGS6 (Regulator of G protein signaling 6) is a member of the RGS protein family, which plays a crucial role in modulating G protein-coupled receptor (GPCR) signaling pathways. It functions as a GTPase-activating protein (GAP) for Gα subunits, accelerating the termination of GPCR signaling by promoting the hydrolysis of GTP to GDP on the Gα subunit (Yang2023Function). RGS6 is involved in various cellular processes, including neuronal signaling and cardiovascular regulation. In the heart, RGS6 is highly expressed in the sinoatrial and atrioventricular nodes, where it modulates parasympathetic activation. It regulates the kinetics of acetylcholine-activated potassium currents (I_KACh) in atrial myocytes, preventing exaggerated bradycardia and maintaining normal heart rate by acting as a negative regulator of G protein activation of GIRK channels (Yang2010RGS6).

RGS6 is also active in the cytoplasm and nucleus, where it influences various signaling pathways. Its role extends to cancer suppression, where it is involved in inhibiting oncogenic transformation and promoting the degradation of oncogenic proteins (Wang2022RGS6). These functions highlight RGS6's importance in maintaining cellular homeostasis and normal physiological processes.

## Clinical Significance
RGS6 (regulator of G protein signaling 6) is implicated in several diseases due to its role in modulating G protein-coupled receptor signaling pathways. In the context of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), RGS6 is downregulated, leading to increased inflammation and oxidative stress, which exacerbates lung damage and mortality in mouse models (Song2023Regulator). 

In Parkinson's disease (PD), RGS6 is crucial for the survival of dopaminergic neurons in the substantia nigra pars compacta. Its loss results in late-age degeneration of these neurons, contributing to PD-like motor deficits (AhlersDannen2020RGS; Bifsha2014Rgs6). RGS6 also regulates α-synuclein accumulation, a protein linked to neurodegeneration in PD (AhlersDannen2020RGS).

In non-small cell lung cancer (NSCLC), RGS6 suppresses TGF-β-induced epithelial-mesenchymal transition (EMT) and metastasis. Its downregulation is associated with poor prognosis and increased cancer progression (Wang2022RGS6). 

RGS6 is also linked to various neuropsychiatric disorders, including schizophrenia, autism spectrum disorder, and major depression, due to its pleiotropic effects on multiple psychiatric conditions (AhlersDannen2021Protein).

## Interactions
RGS6 interacts with several proteins, playing a significant role in various cellular processes. It forms complexes with Gβ5 subunits, which are crucial for the stability and activity of RGS6. This interaction is specific to the GGL domain of RGS6, which binds to Gβ5, similar to conventional Gβ/γ pairings (Anderson2009The; Snow1999Fidelity). The GGL domain is also essential for RGS6's interaction with SMAD4, a key player in the TGF-β signaling pathway. This interaction inhibits the formation of complexes between SMAD4 and R-SMADs, thereby suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) in non-small cell lung cancers (NSCLC) (Wang2022RGS6).

RGS6 also interacts with the transcriptional repressor complex DMAP1/Dnmt1, suggesting a role in nuclear signaling pathways and transcriptional regulation (AbramowNewerly2006RGS; Anderson2009The). Additionally, RGS6 is associated with SCG10, a microtubule destabilizing protein, which enhances neurite outgrowth, indicating a role in cytoskeletal dynamics (Anderson2009The). These interactions highlight the diverse functional roles of RGS6 beyond traditional G protein signaling pathways.


## References


[1. (AhlersDannen2020RGS) Katelin E. Ahlers-Dannen, Mackenzie M. Spicer, and Rory A. Fisher. Rgs proteins as critical regulators of motor function and their implications in parkinson’s disease. Molecular Pharmacology, 98(6):730–738, February 2020. URL: http://dx.doi.org/10.1124/mol.119.118836, doi:10.1124/mol.119.118836. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.119.118836)

[2. (AbramowNewerly2006RGS) Maria Abramow-Newerly, Anju A. Roy, Caroline Nunn, and Peter Chidiac. Rgs proteins have a signalling complex: interactions between rgs proteins and gpcrs, effectors, and auxiliary proteins. Cellular Signalling, 18(5):579–591, May 2006. URL: http://dx.doi.org/10.1016/J.CELLSIG.2005.08.010, doi:10.1016/j.cellsig.2005.08.010. This article has 300 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/J.CELLSIG.2005.08.010)

[3. (AhlersDannen2021Protein) K. E. Ahlers-Dannen, J. Yang, M. M. Spicer, B. Maity, A. Stewart, J. G. Koland, and R. A. Fisher. Protein profiling of rgs6, a pleiotropic gene implicated in numerous neuropsychiatric disorders, reveals multi-isoformic expression and a novel brain-specific isoform. eneuro, 9(1):ENEURO.0379-21.2021, December 2021. URL: http://dx.doi.org/10.1523/ENEURO.0379-21.2021, doi:10.1523/eneuro.0379-21.2021. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1523/ENEURO.0379-21.2021)

[4. (Anderson2009The) Garret R. Anderson, Ekaterina Posokhova, and Kirill A. Martemyanov. The r7 rgs protein family: multi-subunit regulators of neuronal g protein signaling. Cell Biochemistry and Biophysics, 54(1–3):33–46, June 2009. URL: http://dx.doi.org/10.1007/s12013-009-9052-9, doi:10.1007/s12013-009-9052-9. This article has 116 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12013-009-9052-9)

[5. (Israeli2019RGS6) Ran Israeli, Ali Asli, Meirav Avital-Shacham, and Mickey Kosloff. Rgs6 and rgs7 discriminate between the highly similar gαi and gαo proteins using a two-tiered specificity strategy. Journal of Molecular Biology, 431(17):3302–3311, August 2019. URL: http://dx.doi.org/10.1016/j.jmb.2019.05.037, doi:10.1016/j.jmb.2019.05.037. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2019.05.037)

[6. (Wang2022RGS6) Zhao Wang, Jun Chen, Shengjie Wang, Zelong Sun, Zhe Lei, Hong-Tao Zhang, and Jie Huang. Rgs6 suppresses tgf-β-induced epithelial–mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with smad4. Cell Death &amp; Disease, July 2022. URL: http://dx.doi.org/10.1038/s41419-022-05093-0, doi:10.1038/s41419-022-05093-0. This article has 19 citations.](https://doi.org/10.1038/s41419-022-05093-0)

[7. (Yang2010RGS6) Jianqi Yang, Jie Huang, Biswanath Maity, Zhan Gao, Ramón A. Lorca, Hjalti Gudmundsson, Jingdong Li, Adele Stewart, Paari Dominic Swaminathan, Stella-Rita Ibeawuchi, Andrew Shepherd, Ching-Kang Chen, William Kutschke, Peter J. Mohler, Durga P. Mohapatra, Mark E. Anderson, and Rory A. Fisher. Rgs6, a modulator of parasympathetic activation in heart. Circulation Research, 107(11):1345–1349, November 2010. URL: http://dx.doi.org/10.1161/circresaha.110.224220, doi:10.1161/circresaha.110.224220. This article has 97 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/circresaha.110.224220)

[8. (Yang2023Function) Chenglong Yang, Xiaoyuan Zhang, Xiaowen Yang, Fuming Lian, Zongrun Sun, Yongming Huang, and Wenzhi Shen. Function and regulation of rgs family members in solid tumours: a comprehensive review. Cell Communication and Signaling, November 2023. URL: http://dx.doi.org/10.1186/s12964-023-01334-7, doi:10.1186/s12964-023-01334-7. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-023-01334-7)

[9. (Song2023Regulator) Juan Song, Miao Li, Cuicui Chen, Jian Zhou, Linlin Wang, Yu Yan, Jun She, Lin Tong, and Yuanlin Song. Regulator of g protein signaling protein 6 alleviates acute lung injury by inhibiting inflammation and promoting cell self-renewal in mice. Cellular &amp; Molecular Biology Letters, December 2023. URL: http://dx.doi.org/10.1186/s11658-023-00488-z, doi:10.1186/s11658-023-00488-z. This article has 0 citations.](https://doi.org/10.1186/s11658-023-00488-z)

[10. (Snow1999Fidelity) Bryan E. Snow, Laurie Betts, Joan Mangion, John Sondek, and David P. Siderovski. Fidelity of g protein β-subunit association by the g protein γ-subunit-like domains of rgs6, rgs7, and rgs11. Proceedings of the National Academy of Sciences, 96(11):6489–6494, May 1999. URL: http://dx.doi.org/10.1073/pnas.96.11.6489, doi:10.1073/pnas.96.11.6489. This article has 102 citations.](https://doi.org/10.1073/pnas.96.11.6489)

[11. (Bifsha2014Rgs6) Panojot Bifsha, Jianqi Yang, Rory A. Fisher, and Jacques Drouin. Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra. PLoS Genetics, 10(12):e1004863, December 2014. URL: http://dx.doi.org/10.1371/journal.pgen.1004863, doi:10.1371/journal.pgen.1004863. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1004863)